Status:
COMPLETED
A Trial Investigating Telerehabilitation as an add-on to Face-to-face Speech and Language Therapy in Post-stroke Aphasia.
Lead Sponsor:
University of Bern
Conditions:
Aphasia
Chronic Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to investigate the effects of high-frequency short duration tablet-based speech and language therapy (teleSLT) mixed with cognitive training (teleCT) in chronic stroke patient...
Detailed Description
A recent Cochrane intervention review revealed evidence for the effectiveness of using speech and language therapy (SLT) for people with aphasia following stroke in terms of functional communication, ...
Eligibility Criteria
Inclusion
- Aged 18 or over.
- Diagnosis of stroke, onset of stroke at least 3 months prior to inclusion
- Diagnosis of aphasia due to stroke, as confirmed by a speech and language therapist.
- Raw value for the German version of the Token Test (De Renzi \& Vignolo, 1962) has to be smaller or equal to 8 (T-value smaller or equal to 60).
- Sufficient vision and cognitive ability to work with the teleSLT software (a simple matching task on the tablet computer will be used to test this).
- Written informed consent.
Exclusion
- Any other pre-morbid speech and language disorder caused by a deficit other than stroke.
- Requirement for treatment in language other than German.
- Currently using a computer speech therapy software.
Key Trial Info
Start Date :
September 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2021
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03228264
Start Date
September 25 2018
End Date
November 1 2021
Last Update
November 10 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
ARTORG Center for Biomedical Engineering Research
Bern, Switzerland, 3008
2
Center for Neurology and Neurorehabilitation
Lucerne, Switzerland, 6000